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ABSTRACT
Background: The sympatho-adrenergic activation during exercise is implicated in 
many cardiovascular respiratory and metabolic adaptations which have been thought 
to partially explain the different levels of performance observed between trained 
and untrained subjects. To date, no evidence exists about the association between 
competition performance and markers of “acute stress response”. We designed this 
study to investigate; (i) the acute sympatho-adrenergic activation during endurance 
exercise in recreational runners by measuring plasma levels of free metanephrine 
(MN) and normethanephrine (NMN) before and after a half-marathon run; (ii) the 
association between the metanephrines levels and the running time.
Methods: 26 amateur runners (15 males, 11 females) aged 30 to 63 years 
were enrolled. The quantification of MN and NMN was performed by LC-MS/MS. 
Anthropometric ergonomic and routine laboratory data were recorded. Statistical 
analyses included paired T-test, univariate and multivariate regressions.
Results: The post-run values of MN and NMN  displayed a nearly 3.5 and 7 fold 
increase respectively compared to the baseline values (p < 0.0001 for both). NMN 
pre-run values and pre/post run delta values showed a significant direct and inverse 
association (p = 0.021 and p = 0.033, respectively) with running performance. No 
correlations were found for MN values. 
Conclusion: NMN is a reliable marker of sympatho-adrenergic activation by 
exercise and can predict endurance performance in the individual athlete. Adaptation 
phenomenon occurring not only in the adrenal medulla might represent the biological 
mechanism underlying this association. Further studies on sympatho-adrenergic 
activation, competition performance and training status should contemplate the 
measurement of these metabolites instead of their unstable precursors. 
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INTRODUCTION
Catecholamines, namely epinephrine (adrenaline) 
and norepinephrine (noradrenaline), are known to 
play an important role in the adaptive processes in 
response to physical, environmental and psychological 
stressors throughout the activation of the sympatho-
adrenomedullary (SAM) system. A considerable increase 
of catecholamine plasma levels has been reported in 
many conditions, including physical exercise [1], insulin 
induced hypoglycemia [2], hypoxia and hipercapnia [3], 
and caffeine intake [4, 5]. 
In normal conditions, the synthesis of norepinephrine 
occurs mostly within the sympathetic nervous fibre 
extremities and, to a lesser extent, within chromaffin cells 
of adrenal medulla. Unlike norepinephrine, epinephrine 
is almost entirely synthetized and released from the 
adrenal medulla gland in response to direct stimulation of 
sympathetic nervous system, adrenocorticotropic hormone 
and/or cortisol [6]. Both hormones act as messengers of 
the SAM system, as nonselective agonists of α (subtypes 
α1 and α2) and β (subtypes β1 and β2) adrenergic receptors. 
Norepinephrine preferentially binds to α-receptors, while 
epinephrine preferentially binds to β-receptors, although 
their selectivity depends on the circulating concentration 
[7, 8]. Briefly, the activation of α1-receptors increases total 
peripheric resistance (TPR), blood pressure (BP), which 
may elicit a reflex bradycardia, and provokes constriction 
of bronchial smooth muscle and gastrointestinal smooth 
muscles relaxation, whilst α2-receptors activation 
decrease sympathetic outflow. On the other hand, β1-
receptor stimulation is associated with enhanced heart 
rate (positive chronotropy), stroke volume, cardiac output, 
pulse pressure, and cardiomyocyte contractility, while 
β2-receptor stimulation induces skeletal muscle arterial 
vasodilatation, bronchial smooth muscle relaxation, 
increases skeletal muscle and liver glycogenolysis, 
and increases lipolysis [9, 10]. Since epinephrine is 
metabolized to metanephrine (MN) and norepinephrine 
is metabolized to normetanephrine (NMN), these 
free circulating metanephrines (i.e., catecholamine 
metabolites) are commonly used to identify increases in 
sympathoadrenal function [11, 12].
An increased adrenergic tone leads to higher 
circulating catecholamines levels, which is a characteristic 
of the adaptation of the organism to exercise [13]. The 
sympathoadrenal response to physical exercise increases 
respiratory, cardiac, metabolic and thermoregulatory 
functions depending on specific exercise characteristics 
(i.e., type, duration and intensity). For instance, 
endurance exercise leads to remodeling of the heart 
muscle by adrenergic inputs, including an adaptive (or 
“physiological”) hypertrophy process [14]. Sympathetic 
nervous system stimulation triggers metabolic processes 
that increase both perfusion pressure of the coronary 
artery and coronary vasodilation. This is a “healthy” 
compensatory mechanism, necessary to maintain an 
increased demand [15, 16]. In effect, endurance exercise-
induced changes in human heart anatomy have been 
extensively described (athlete’s heart) [17]. Likewise, 
other factors such as age, gender, nutritional and emotional 
status may have an influence on catecholamine release in 
exercising subjects [1]. 
Controversy remains on the influence of training 
status on catecholamine responses to exercise at the same 
absolute and/or relative intensity. Although higher post-
exercise epinephrine plasma concentrations have been 
occasionally described in endurance and sprint-trained 
athletes compared to untrained subjects, or in anaerobic-
trained athletes compared to aerobic-trained subjects, 
others studies failed to observe a significant effect of 
endurance training [1, 18]. Evidence collected in animal 
studies seems more consistent to suggest that physical 
training may be effective to increase epinephrine secretory 
capacity by inducing adrenal gland hypertrophy [19, 20].
This phenomenon, known as “sport adrenal 
medulla”, may partially explain the higher physical 
performance observed in trained compared with untrained 
subjects. According to this hypothesis, athletes with higher 
basal nocturnal catecholamine excretion (BNCE) may 
obtain better competitive results or athletic performance 
than those with lower levels. This finding has been 
consistently observed in competitive cross-country skiers 
[21], basketball players [22], sky-flyers [23], and military 
ongoing flight missions [24], thus suggesting the existence 
of a relationship between competition performance and 
“average sympathetic activity” of individual athletes. 
Nevertheless, studies evaluating the association between 
competition performance and “acute stress response” are 
still lacking to the best of our knowledge. 
Therefore, we designed this study to investigate: 
(i) the acute sympathoadrenal activity during endurance 
exercise in recreational runners by measuring the plasma 
levels of free metanephrines, i.e., MN and NMN, before 
and after a half-marathon run; (ii) the association 
between the circulating levels of metanephrines and the 
running time as a reliable index of competitive athlete’s 
performance. 
RESULTS
The baseline characteristics of the athletes are 
summarized in Table 1. The post-run values of MN (354.5 
pmol/L; range, 105–1058 pmol/L) displayed a nearly 3.5 
fold increase compared to the baseline values measured 
before the run (118.5 pmol/L; range, 14–222 pmol/L; p < 
0.0001) (Figure 1). Six and 24 hours after the run, the MN 
returned to values comparable to the basal concentration 
(95 pmol/L; range, 39–232 pmol/L; p = 0.6373 and 
116.5 pmol/L; range, 59–180 pmol/L; p = 0.2575). The 
post-run concentration of NMN displayed a nearly 7-fold 
increase compared to the baseline values measured before 
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the run (2685.5 pmol/L; range, 1432–5563 pmol/L vs 
488.5 pmol/L; range, 158–798 pmol/L; p < 0.0001). 
Unlike MN, the plasma concentration of NMN measured 
at 6 and 24 h after the run remained significantly higher 
than the pre-run concentration (715 pmol/L; range, 362–
1704 pmol/L; p < 0.0001 and 652.5 pmol/L, range, 359–
993 pmol/L; p = 0.0031). Moreover, the concentration of 
NMN measured 24 hours after the run was lower than that 
measured 6 hours after the run (p = 0.0026).
The delta values of both MN and NMN did not 
significantly correlate with any anthropometric baseline 
characteristic or laboratory data. Nevertheless, a statically 
significant correlation was found between NMN variation 
and VO2max (r = 0.663, p = 0.005). Interestingly, the pre-
run values of NMN were found to be inversely correlated 
with NMN delta values (Figure 2).
In univariate analysis, running performance was 
found to be significantly associated with sex (r = 0.418, p 
= 0.025), age (0.300, p = 0.049), capillary blood lactate (r 
= –0.590, p = 0.001), pre-run NMN values (r = 0.451, p 
= 0.021) and NMN delta values (r = –0.418, p = 0.033). 
These two last associations are shown in Figure 3. In 
multivariate analysis, where running time was entered 
as a dependent variable and the parameters significantly 
associated with running performance in univariate analysis 
were entered as independent variables, all parameters 
were confirmed to be significant predictors of running 
performance (Table 2). Due to the correlation between 
delta and pre-run NMN values, the former was not entered 
in the multivariable model. The combination of gender, 
sex, age, blood lactate and delta values of NMN predicted 
82.2% (95% CI, 73.8–90.6%; p < 0.001) of variance in 
running performance. 
DISCUSSION
The biology of sympatho-adrenergic activation 
in response to exercise has been a matter of debate for 
almost 30 years. Available evidence suggests that acute 
exercise may be effective in significantly increasing blood 
catecholamine concentrations in healthy subjects, and 
that this increase may be dependent on exercise intensity 
[25, 26]. Moreover, it is more probable that it is related 
to increased secretion than to an impaired clearance or a 
decreased elimination [27]. Nevertheless, reliable studies 
aimed to assess the association between competitive 
Figure 1: MN and NMN values at different time point before and after the half-marathon run. *Significant difference with 
respect to pre-run values.
Table 1: Demographical, anthropometric and ergonomic data 
Median (range)
Age (years) 47 (30–63)
Gender (M/F) 15/11
BMI (Kg/m2) 22.8 (18.5–27.8)
VO2max (mL/kg/min) 49.5 (40.6–58.0)
Running performance (min) 112 (91–149)
VO2max, maximal oxygen uptake
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endurance performance and markers of acute sympatho-
adrenergic activation have been missing up until now. 
This is the first study that evaluates the effect of endurance 
exercise on plasma circulating metanephrines and their 
association with athlete’s running performance.
The measurement of metanephrines instead of their 
precursors, i.e., catecholamines, is usually considered 
more reliable for at least two reasons. First, plasma free 
metanephrines are conventionally regarded as more 
reliable biomarkers of adrenal medulla responsiveness 
to exercise compared to plasma catecholamines. The 
adrenal gland constitutes the single largest source of both 
MN and NMN, which contributes to approximately 90% 
and 23% of the circulating pool of these two hormones, 
respectively. On the other hand, plasma norepinephrine 
mainly derive from sympathetic nerves, whilst adrenal 
gland secretion only contributes for 7% of the circulating 
pool [28]. Plasma circulating metanephrines therefore 
seem to be a more suitable biomarker in assessing the 
contribution of adrenal medulla hypertrophy in predicting 
athletic performance. Then, the stability of plasma free 
metanephrines is much higher than that of catecholamines, 
and the former class of metabolites also has a more 
favorable pharmacokinetics profile [11]. Finally, 
metanephrines measurement has now completely replaced 
the assessment of plasma and urinary catecholamines 
for diagnosing and monitoring pheochromocytoma, 
as recommended by current guidelines [29], so that 
innovative methods have been specifically developed 
for allowing metanephrines quantification with high 
sensitivity and specificity [30]. 
Regarding the results of our study, the plasma 
concentrations of both MN and NMN were found to be 
significantly enhanced after a half-marathon run, despite 
the kinetics of both hormones being consistently different. 
The magnitude of increase of plasma NMN was more 
marked (i.e., almost double) than that of MN. Moreover, 
6 hours after the end of the run the plasma concentration 
of MN was similar to that measured before the run, whilst 
plasma NMN levels persisted significantly increased even 
24 hours after the end of the run.
Interestingly, both pre-run and delta value of NMN 
were significantly associated with running time. More 
specifically, better running performances were achieved by 
Figure 2: Correlation between pre-run and delta percentage values of NMN.
Figure 3: Linear regression analyses of NMN pre-run and delta values and running performance.
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subjects with lower basal values and higher delta variation 
during the run, the latter case thus reflecting a higher 
secretion in response to exercise. These results, along 
with the significant correlation observed between delta 
variation of NMN and VO2max, suggests the existence of an 
association between endurance performance and improved 
adaptation of sympathoadrenal system. According to the 
“sport adrenal medulla” hypothesis, the training status 
of the athletes may be the reason of the observed data, 
since trained subjects might have decrease metanephrines 
release at rest and higher catecholamine secretion capacity 
compared to less trained individuals, thus providing them 
an adaptive advantage in terms of athletic performance 
[18]. Nevertheless, it is quite surprising that similar 
findings could not be replicated for MN. This hormone 
is almost entirely produced by the adrenal gland, whereas 
only 23% of the NMN circulating pool originates from the 
adrenal gland [28]. Therefore, factors other than training-
induced adaptation of adrenal gland secretion capacity 
may come into play to explain the association between 
plasma NMN and endurance performance.
Important differences exist in the extra-neuronal 
production of MN and NMN [28]. The largest part of 
circulating MN (i.e., up to 90%) originates from the 
metabolism of locally released epinephrine, whilst a minor 
fraction (i.e., around 6%) is derived from the metabolism 
of circulating epinephrine. The spillover rate of MN 
originating from locally-released epinephrine is almost 
entirely attributable to adrenal gland production, whilst 
the amount of hormone derived from the metabolism 
of epinephrine removed from plasma is almost equally 
sustained by liver and the lung tissues. Unlike MN, the 
spillover rate of NMN originated from metabolism of 
locally-released norepinephrine approximates 80%. The 
individual adrenal medulla contributes to the largest part 
of this pool (i.e., 23%), whereas skeletal muscle, lung, 
kidney, mesenteric organs and liver almost contribute 
to the remaining fraction. Circulating norepinephrine 
metabolism contributes to 19% of total NMN production. 
Interestingly, the liver not only is the largest site of 
norepinephrine catabolism (57%), but also the organ which 
contribute most to the synthesis of NMN from metabolism 
of circulating norepinephrine (54%). Accordingly, adrenal 
gland and liver contribute to 23% and 20% of the overall 
circulating pool of NMN, respectively [28]. 
Due to heterogeneous pathways of metanephrines 
metabolism, and to the variable contribution to the overall 
MN and NMN spillover of various tissues and organs, 
the different association observed between endurance 
performance and each of these two hormones is not really 
surprising. We can therefore speculate that the biological 
interplay between NMN and running performance should 
be sought as an adaptive phenomenon occurring not only, 
and not primarily, in the adrenal gland, but more likely in 
other tissues, especially in the liver. 
Symphatoadrenal system and catecholamines 
fluctuations are without doubt involved in cardiovascular, 
respiratory, metabolic and skeletal muscle adaptations 
induced by exercise. Although many aspects should 
be elucidated, this is the first study demonstrating a 
significant association between endurance performance 
and NMN, an extensively described marker of acute 
symphatoadrenal activation. Even more interestingly, 
a multivariate model incorporating variation of plasma 
NMN before and after the run, age, gender and capillary 
blood lactate could explain over 80% variance in running 
performance.  
Notably, these results cannot be straightforwardly 
transferred to professional athletes, who are supposed 
to have higher values of stress-related hormones due to 
their intensive training, jet-lag, competitions stressors, and 
additional issues which can magnify the release of these 
molecules. We also acknowledge that more comprehensive 
information may have been generated by analyzing other 
stress hormones such as cortisol and ACTH. Although 
plasma MN and NMN are non-functional hormone, 
they both correlate with the respective catecholamines 
epinephrine and norepinephrine [31]. The measurement 
of metanephrines has several advantages over that of 
catecholamines, in that the former class of hormones 
is not significantly influenced by circadian rhythm, 
menstrual cycle or venipuncture. Metanephrines are also 
characterized by a longer half-life [32], are stable when 
stored at 4° C for 72 h after separation [33] and can now 
be measured with high sensitivity and specificity by LC-
MS/MS [34]. Therefore, our preliminary findings pave 
the way for further studies aimed to define whether or not 
NMN assessment may provide valuable information for 
predicting endurance performance in the individual athlete 
and, eventually, validate this measure as a surrogate marker 
for early identification of overreaching and overtraining. It 
cannot also be excluded that subjects in overtraining might 
present a blunted  metanephrines release in response to 
exercise similar to that already observed for other stress 
Table 2: Multivariate analysis showing independent predictors of running performance
Independent variables β coefficient P value
Age (years) 0.75 0.003
NMN ∆% (pmol/L) –0.012 0.004
Gender –11.4 0.008
Capillary blood lactate (mmol/L) –2.6 0.023
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hormones such as prolactin, ACTH and growth hormone 
(GH), as a physiological response in the initial stages of 
relative glands dysfunction [35]. Therefore, additional 
studies should be planned to define whether or not 
metanephrines assessment may complement these measure 
for enabling an improved and earlier identification of both 
overreaching and overtraining.
The measurement of plasma metanephrines instead 
of their parent cathecolamines in further studies might 
be the key to resolve the great amount of inconsistent 
results reported in literature on the association between 
sympathoadrenal activation, competition performance 
and training status. Moreover, a definitive answer on the 
biological mechanism linking the association between 
NMN values and running performance will come 
from large prospective studies taking into account an 
appropriate monitoring of the individual training load in 
the preparation of competition. 
MATERIALS AND METHODS
The study was conducted during an event formally 
known as ‘Run For Science’, which took place in the 
town of Verona (Italy) in April 2014, and which was 
specifically planned to assess the individual response 
of recreational athletes to endurance running. Detailed 
information about this event has been previously 
published [36]. Briefly, in this study we enrolled 26 
amateur runners who successfully concluded a 21.1 km 
(half-marathon) run between 75%–85% of their maximal 
oxygen uptake (VO2max). All these athletes were part of an 
amateur team and were engaged in habitual recreational 
running (median training regimen, 200 min/week). The 
VO2max was measured before the event by means of 
a running test on a treadmill using a breath by breath 
ergospirometric system (Quark B2, Cosmed Italy). The 
trial started at 9.30 a.m. The run distance was covered 
on a relatively flat route, around the city of Verona (35 
m vertical gain, maximal slope of 1.8%). The day was 
partially sunny, with temperatures comprised between 
12–19° C and humidity comprised between 55–75%. All 
participants were allowed to drink ad libitum throughout 
the running distance, but were not allow to ingest 
carbohydrates.
Blood samples, obtained by venipuncture, were 
collected before the run and immediately afterwards 
in primary blood tubes containing either K2EDTA (for 
obtaining plasma EDTA) or no additives (for obtaining 
serum). Two additional plasma and serum samples were 
collected 6 and 24 hours after the end of the run. The 
samples were immediately transported to the laboratory 
of clinical biochemistry  of the University Hospital of 
Verona, under controlled conditions of temperature 
(i.e., between 4–8° C). Immediately upon arrival in the 
laboratory, all blood tubes were centrifuged for 10 min 
at 1300 × g. The serum samples were then used for 
performing routine clinical chemistry testing, whilst 
plasma EDTA samples were aliquoted and stored at 
–80° C for later batch analysis of metanephrines. Capillary 
blood lactate was also assessed at the end of the run, from 
the ear lobe, using a Biosen C-Line Sport Analyzer (EKF 
Diagnostics, Magdeburg, Germany). The panel of serum 
analytes tested is reported in Supplementary Table 1, 
along with the pre- and post-run data. The analytical 
performance of all tests has been previously described 
elsewhere [37]. None of the participants in this study had 
taken medications the 2 days before the trial.
The quantification of plasma levels of MN and NMN 
was performed with a ClinMass Complete kit (Recipe, 
Munchen, Germany), by using liquid chromatoghraphy 
tandem mass spectrometry (LC-MS/MS). The LC-MS/
MS analytical system was a Nexera X2 series UHPLC 
(Shimadzu, Kyoto, Japan) coupled with a 4500 MD triple 
quadrupole MS detector (Sciex, Milan, Italy). Sample 
processing was performed via solid phase extraction 
(SPE) which provided sample purification and enrichment 
in metanephrines content. The electrospray ionization 
was carried out in positive mode. Data were recorded 
in multiple reaction monitoring mode (MRM). Analyst 
1.6.2. and Multiquant 3.0.2. softwares (Sciex) were used 
for data acquisition and quantification, respectively. The 
method was found to be linear up to 100000 pmol/L for 
both metanephrines and was characterized by a limit of 
quantitation (LOQ) of 20 pmol/L. The mean intra- and 
inter-assay imprecision, as assessed using three plasma 
pools with different metanephrines concentrations, were 
comprised between 1.7–3.9% for MN and between 3.2–
6.2% for NMN, respectively.
Demographical, physiological and ergonomic 
data of the participants are shown in Table 1. Normal 
distribution of variables was tested by Kolmogorov-
Smirnov test. Differences between pre- and post-run values 
were analyzed with Wilcoxon’s test for paired samples or 
paired Student’s T-test, when appropriate. Adjustment 
for body weight change throughout the study period 
did not generate significantly different results, and was 
hence disregarded (data not shown). Pearson’s correlation 
was used to test the association between metanephrines 
delta value (i.e., the percentage difference between pre- 
and post-run values), ergonomic and laboratory values. 
Univariate and multivariate linear regression analyses 
were also conducted for identifying variables significantly 
associated with running performance. Results are shown 
as median and range.
The statistical analysis was performed with Analyse-
it (Analyse-it Software Ltd, Leeds, UK). Figures were 
achieved by using GraphPad Prism 5.01 (San Diego, 
California). All subjects provided a written consent 
for being enrolled. The study was approved by the 
local Ethical Committee (Department of Neurological, 
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Neuropsychological, Morphological and Movement 
Sciences, University of Verona). 
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